Elevated serum levels of soluble CD14 in HBeAg‐positive chronic HBV patients upon Peginterferon treatment are associated with treatment response

Pegylated IFNα (PEG‐IFN) is one of the treatment options for chronic HBV (CHB) patients. However, the high patient treatment burden and limited response rate together clearly ask for biomarkers to predict PEG‐IFN response. Soluble CD14 (sCD14) is considered a marker for immune activation and has bee...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Viral Hepat
Hoofdauteurs: Dou, Yingying, van Montfoort, Nadine, van den Bosch, Aniek, Janssen, Harry L. A., de Man, Robert A., Buschow, Sonja I., Woltman, Andrea M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852593/
https://ncbi.nlm.nih.gov/pubmed/31090247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13127
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items